Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Policy / Pricing
  • FDA Advances Drug Repurposing to Address Unmet Medical Needs
  • Policy / Pricing

FDA Advances Drug Repurposing to Address Unmet Medical Needs

FDA

FDA announced it is soliciting input on efforts with respect to drug repurposing to help address unmet medical needs across a range of diseases and conditions.

Read full story

pharminent May 11, 2026 (Last updated: May 16, 2026)

FDA

FDA announced it is soliciting input on efforts with respect to drug repurposing to help address unmet medical needs across a range of diseases and conditions.

Read full story

Post navigation

Previous: Daiichi takes $850M charge, axes facility investment as ADC demand forecast falls
Next: What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge

Related Stories

  • Policy / Pricing

MFN affecting Swiss medicines access, says Interpharma

pharminent August 13, 2026
  • Policy / Pricing

Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain

pharminent August 13, 2026
  • Policy / Pricing

Trump signs order that nearly halves childhood immunisation coverage

pharminent August 11, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.